Public–private partnerships boost research on neglected diseases
نویسندگان
چکیده
منابع مشابه
Jumpstarting Research into Neglected Diseases
Unwilling to wait and hope for a cure, patients suffering from rare or little-studied diseases and their families are galvanizing research efforts and driving innovative approaches to develop new treatments.
متن کاملProgress in public-private partnerships to fight neglected diseases.
In the global fight against neglected tropical diseases (NTDs), public health partnerships involving donations of medicines by pharmaceutical companies are enabling access to treatment for millions of people worldwide. These partnerships collaborate with other disease programs and a range of key stakeholders to develop and improve programs to control and eliminate NTDs. Although progress is bei...
متن کاملInnovative Partnerships for Drug Discovery against Neglected Diseases
There is a compelling scarcity of pharmaceutical agents for efficacious, safe, and affordable treatment of neglected infectious or tropical diseases such as malaria, trypanosomiasis, leishmaniasis, dengue, lymphatic filariasis, and soiltransmitted helminths, despite their high prevalence in the developing world. Toxicity of drugs, microbial resistance patterns, and long courses of treatments ar...
متن کاملRisk allocation and the costs and benefits of publicprivate partnerships
We study the agency costs of delegated public service provision, focusing on the link between organizational forms and uncertainty at project implementation. We consider a dynamic multitask moral hazard environment where the mapping between effort and performance is ex ante uncertain but new information may arise during operations. Our analysis highlights the costs and benefits that bundling pl...
متن کاملNeglected Tropical Diseases: Research Bites Back
Progress toward the treatment of three major parasitic diseases (sleeping sickness, Chagas disease, and leishmaniasis) was recently demonstrated in an article published online last month in the journal Nature (August 8, 2016). Collectively, these three diseases affect 20million people per year, resulting in 50 thousand deaths. Researchers were able to identify and optimize a small molecule that...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2003
ISSN: 1087-0156,1546-1696
DOI: 10.1038/nbt903